Karyopharm Therapeutics (KPTI) Earnings Date, Estimates & Call Transcripts → $5,000 Gold? (From Stansberry Research) (Ad) Free KPTI Stock Alerts $1.08 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 2EstimatedActual EPS (Feb. 29) -$0.36 Missed By -$0.07 Consensus EPS (Feb. 29) -$0.29 Read Call TranscriptListen to Call Get Karyopharm Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for KPTI and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueKPTI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KPTI Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressBiden out June 13; Kamala won’t replace him?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. Karyopharm Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($0.37)($0.09)($0.27) Q2 20242($0.32)($0.08)($0.20) Q3 20243($0.30)($0.06)($0.21) Q4 20242($0.24)($0.06)($0.15) FY 202410($1.23)($0.29) ($0.83)KPTI Earnings Date and InformationKaryopharm Therapeutics last announced its earnings data on February 29th, 2024. The reported ($0.36) earnings per share for the quarter, missing analysts' consensus estimates of ($0.29) by $0.07. The business earned $33.75 million during the quarter, compared to analyst estimates of $33.50 million. Karyopharm Therapeutics has generated ($1.25) earnings per share over the last year (($1.25) diluted earnings per share). Earnings for Karyopharm Therapeutics are expected to grow in the coming year, from ($1.19) to ($1.05) per share. Karyopharm Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.Read More Karyopharm Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/2/2024Estimated)------- 2/29/2024Q4 2023($0.29)($0.36)($0.07)($0.36)$33.50 million$33.75 million 11/2/2023Q3 2023($0.28)($0.30)($0.02)($0.30)$37.34 million$36.01 million8/2/2023Q2 2023($0.34)($0.29)+$0.05($0.29)$36.23 million$37.58 million5/4/2023Q1 2023($0.34)($0.30)+$0.04($0.30)$37.87 million$38.70 million2/15/2023Q4 2022($0.34)($0.43)($0.09)($0.43)$33.88 million$33.58 million 11/3/2022Q3 2022($0.56)($0.45)+$0.11($0.45)$34.82 million$36.15 million Get the Latest News and Ratings for KPTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Karyopharm Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($0.63)($0.62)+$0.01($0.62)$36.38 million$39.68 million5/5/2022Q1 2022($0.63)($0.53)+$0.10($0.53)$34.78 million$47.67 million 2/8/2022Q4 2021($0.40)$0.46+$0.86$0.46$55.98 million$126.27 million 11/3/2021Q3 2021($0.68)($0.69)($0.01)($0.69)$25.84 million$37.69 million 8/5/2021Q2 2021($0.72)($0.71)+$0.01($0.71)$26.86 million$22.60 million 5/2/2021Q1 2021($0.71)($0.77)($0.06)($0.77)$26.50 million$23.26 million Karyopharm Therapeutics Earnings - Frequently Asked Questions When is Karyopharm Therapeutics's earnings date? Karyopharm Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on KPTI's earnings history. Did Karyopharm Therapeutics beat their earnings estimates last quarter? In the previous quarter, Karyopharm Therapeutics (NASDAQ:KPTI) missed the analysts' consensus estimate of ($0.29) by $0.07 with a reported earnings per share (EPS) of ($0.36). Learn more on analysts' earnings estimate vs. KPTI's actual earnings. How can I listen to Karyopharm Therapeutics's earnings conference call? The conference call for Karyopharm Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Karyopharm Therapeutics's conference call transcript? The conference call transcript for Karyopharm Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Karyopharm Therapeutics generate each year? Karyopharm Therapeutics (NASDAQ:KPTI) has a recorded annual revenue of $146.03 million. How much profit does Karyopharm Therapeutics generate each year? Karyopharm Therapeutics (NASDAQ:KPTI) has a recorded net income of -$143.10 million. KPTI has generated -$1.25 earnings per share over the last four quarters. What is Karyopharm Therapeutics's EPS forecast for next year? Karyopharm Therapeutics's earnings are expected to grow from ($1.19) per share to ($1.05) per share in the next year. More Earnings Resources from MarketBeat Related Companies: RPTX Earnings Date CTXR Earnings Date VTGN Earnings Date ANVS Earnings Date EBS Earnings Date AMLX Earnings Date GLYC Earnings Date RLMD Earnings Date INCR Earnings Date PDSB Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: PayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting Season This page (NASDAQ:KPTI) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsThe A.I. story nobody is telling you (Read ASAP)TradeSmithAI “wealth window” is closing June 25thParadigm Press4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karyopharm Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.